ArticleEuropean journal of medical research2023

B7-H3 chimeric antigen receptor-modified T cell shows potential for targeted treatment of acute myeloid leukaemia.

Shuangshuang Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.